Aimei Health Technology Co., Ltd. received notices from Nasdaq on August 21, 2026, indicating non-compliance with minimum Market Value of Listed Securities ($50 million) and Market Value of Publicly Held Shares ($15 million) requirements for the last 30 consecutive business days. The company has an 180-day compliance period until February 17, 2027, to regain adherence by maintaining the required market values for ten consecutive business days. Failure to comply may result in delisting from the Nasdaq Global Market or a transfer to the Nasdaq Capital Market. Aimei Health Technology Co., Ltd. operates in the health technology sector.

Aimei Health Technology Co., Ltd. deposited $34,330.96 into its trust account to extend the deadline for consummating an initial business combination by one month, from August 6, 2026, to September 6, 2026. This payment represents the 21st permitted extension under the company's articles of association and is calculated at $0.033 per outstanding public share. To fund this amount, the company issued an unsecured promissory note for $34,330.96 to Aimei Health Ltd., which bears no interest and becomes due upon the completion of a business combination with United Hydrogen. The payee holds the right to convert the note into private units at $10.00 per unit prior to closing. This company operates in the healthcare technology sector, specifically functioning as a special purpose acquisition company (SPAC) seeking a merger target.

Aimei Health Technology Co., Ltd. extended the deadline to consummate its initial business combination with United Hydrogen from July 6, 2026, to August 6, 2026. This twentieth extension was funded by a $34,330.96 deposit into the public shareholders' trust account. To fund this payment, the company issued a non-interest-bearing unsecured promissory note for $34,330.96 to Aimei Health Ltd, which is payable upon the closing of the business combination or convertible into private units at $10.00 per unit. The company is a special purpose acquisition company (SPAC) operating in the healthcare technology sector.